Authorized distributor of Erchonia

Opening Hours : Open 24/7 for your convenience!
  Contact : (310) 692-9185

Zerona Medical Laser

01

The ERCHONIA® Laser Scanner is specially designed for use during Liposuction and non-invasive body contouring (ZERONA®). The medical laser is applied externally and has proven through double-blind clinical trials to emulsify adipose tissue. 

ZERONA® is a new body-sculpting procedure designed to remove fat and contour the body without invasive surgery. ZERONA® unlike other procedures, allows the patient to continue their daily activities without interruptions from surgery, pain, wounds or garments. 

ZERONA® works by utilizing the Erchonia® Laser Scanner (FDA market cleared for laser assisted liposuction) to emulsify adipose tissue which then releases into the interstitial space. The excess fat is passed through the body during its normal course of detoxification.

The ZERONA®procedure was proven through a double-blind, randomized, multi-site, and placebo controlled study in which patients averaged a loss of 3-4 inches compared to the placebo group that lost only a half an inch. 

Purchase a Zerona machine: Contact us to buy Zerona, Zerona-AD, or Verju device for your office.

Get listed as an official provider when you purchase through us.

My Zerona and Find Zerona
02

Zerona is the first non-invasive body contouring procedure to effectively remove excess fat without the negative side effects associated with surgical methods. Zerona utilizes the same cold laser technology developed by Erchonia, which has been shown to emulsify fat and allow it to move to interstitial space. Although this technology was originally utilized to help assist tumescent liposuction procedures, it was found that the cold laser treatment alone helped patients to reduce inches from their waist, hip and thighs.

Zerona

The cold laser technology behind the Zerona procedure was shown to exclusively release the cellular contents of fat cells while leaving the capillaries and other cells within the interstitial space intact. The release of the fat cell contents is the result of the disruption of the cell’s membrane. This membrane disruption, called a transitory pore, is the result of low-level laser stimulation. Prior to laser exposure, fat cells have a regular, cluster shape, as seen in Figure 4. Within minutes of low level laser exposure, fat cells begin to develop transitory pores as indicated by arrows in Figures 6-9. This pore allows the evacuation of the cell’s contents into extracellular space (see Figure 7). Once the contents of the fat cell have been emptied (Fig. 10), they are released into interstitial space where it can be passed through the body during its normal course of detoxification.

Through a double blind, randomized, multi-site and placebo-controlled study, the Zerona procedure is proven to be an effective non-invasive and body contouring procedure. On average, patients lost on average 3.64 inches from the circumference of their waist, hip and thighs, whereas the placebo group only lost an average of a half of an inch. The Zerona cold lasers provide patients with a safer alternative to surgical procedures, which can result in bruising, swelling, and damage to other tissues. There is no need to wear bandages with Zerona and since there is no pain, there is no need for anesthesia. Unlike other non-invasive approaches, Zerona low-level lasers do not rely on heating tissue, which can cause discomfort. There is no downtime, so patients can resume their normal activities immediately.